# DOLUTEGRAVIR; RILPIVIRINE
> **ANDA213120** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN LTD · Approved 2023-01-13
## Drug
- **FDA Application Number:** ANDA213120
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOLUTEGRAVIR; RILPIVIRINE
- **Generic name:** Dolutegravir
- **Active ingredients:** DOLUTEGRAVIR; RILPIVIRINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** LUPIN LTD
- **First approval:** 2023-01-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213120)
---
*AI Analytics · CC0 1.0*